Search results for: “keytruda”

Blog
Immunotherapy for Blood Cancers: What to Look for at the Upcoming ASH Meeting

Look for the latest results from trials of PD-1 inhibitors and new developments in adoptive cell transfer.

December 1, 2014| Jill O'Donnell-Tormey, PhD
Blog
FDA Approves New Cancer Immunotherapy

Merck's new immunotherapy, Keytruda (pembrolizumab), was approved today by the FDA, making it the first PD-1 inhibitor…

September 4, 2014| Jill O'Donnell-Tormey, PhD